1476-1477 / 2437
N
Sex/Age at diagnosis
(months)
Residual
disease
Time of relapse
from diagnosis
Site of relapse
Outcome
(months from relapse)
Subsequent
treatment
1
M (31.1)
-
9.5
Local
Alive (14.4)
Surgery, CT, SCT
2
M (31.9)
+
9.7
Distant
Alive (14.9)
CT, RT
3
F (32.0)
-
10.5
Distant
DOD (2.9)
na
4
M(21.3)
-
13.7
Local
Alive (8.8)
na
5
F(31.4)
-
9.9
Combined
Alive (9.9)
CT
6
M(27.2)
+
8.9
Combined
Alive (5.3)
CT
7
M(20.8)
-
11.7
Distant
Alive (0.2)
na
8
M(17.2)
-
9.6
Combined
Alive (0.1)
na
9
M(24.4)
-
9.7
Local
Alive (2.9)
CT
10
M(26.7)
-
11.7
Local
Alive (0.7)
na
11
M(26.9)
-
10.9
Local
Alive (at time of relapse)
na
12
M(15.8)
-
9.8
Local
Alive (at time of relapse)
na
Relapses
Lucie Lafay-Cousin ASCO meeting Chicago June 03rd 2017